Glaxo Smith Kline Faces Bribery Charges in China

Several business executives at Glaxo Smith Kline are accused of bribing local officials and doctors in China. Eunice Yoon has the story for NBR.

This entry was posted in Asia, Crime and Law. Bookmark the permalink.

Leave a Reply